Wide variation in the number of different drugs prescribed by general practitioners. A prescription database study

Scandinavian Journal of Primary Health Care

Volumn 18, Issue 2, 2000, Pages 94-98

  Bjerrum, Lars ^a   Bergman, Ulf ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Database; Drug use; Formularies; General practice; Variation

Indexed keywords

ANTIHISTAMINIC AGENT; ANTIULCER AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYPNOTIC AGENT; LOOP DIURETIC AGENT; MACROLIDE; NEUROLEPTIC AGENT; NITRIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PENICILLIN DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; TETRACYCLINE DERIVATIVE; THIAZIDE DIURETIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; DATA BASE; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HUMAN; MEDICAL PRACTICE; PRESCRIPTION; PRIMARY HEALTH CARE; WORKLOAD;

EID: 0033941588     PISSN: 02813432     EISSN: None     Source Type: Journal    
DOI: 10.1080/028134300750018972     Document Type: Article

References (16)

1. Chinburapa V, Larson LN, Brucks M, Draugalis J, Bootman JL, Puto CP. Physician prescribing decisions: The effects of situational involvement and task complexity on information acquisition and decision making. Soc Sci Med 1993;36:1473-82.
2. Dukes M, Drug utilization studies. Methods and uses. 45th ed. Copenhagen: WHO Regional Publications European Series No. 45, 1993.
3. Frolund F. Laegemiddelordinationer i almenpraksis (Drug prescriptions in general practice). Ugeskr Laeger 1991;153:167-8.
4. Hartzema AG, Christensen DB. Nonmedical factors associated with the prescribing volume among family practitioners in an HMO. Med Care 1983;21:990-1000.
5. McCarthy M, Wilson Davis K, McGavock H. Relationship between the number of partners in a general practice and the number of different drugs prescribed by that practice. Br J Gen Pract 1992;42:10-2.
6. Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997;44:445-8.
7. Rønning M, Strøm H, Blix H, Harbo B, Litleskare I, Ullerud T. Guidelines for ATC classification and DDD assignment (5th ed.). Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 1998.
8. Bergman U, Popa C, Tomson Y, Wettermark B, Einarson TR, Aberg H. et al. Drug utilization 90% - a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 1998;54:113-8.
9. Hallas J, Gaist D, Bjerrum L. The waiting time distribution as a graphical approach to epidemiologic measures of drug utilization. Epidemiology 1997;8:666-70.
10. Norusis MJ, SPSS/PC + Professional Statistics. Chicago: SPSS Inc., 1993.
11. Speight TM, Holford HG. Avery's drug treatment (4th ed.) Adis International Limited, 1997.
12. Henry D, Lim LL, Garcia RL, Perez GS, Carson JL, Griffin M, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis. Br Med J 1996;312:1563-6.
13. Tamblyn RM, McLeod PJ, Abrahamowicz M, Laprise R. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. Can Med Assoc J 1996;154:1177-84.
14. Beardon PH, Brown SV, Mowat DA, Grant JA, McDevitt DG. Introducing a drug formulary to general practice - effects on practice prescribing costs. JR Coll Gen Pract 1987;37:305-7.
15. Bjerrum L. Pharmacoepidemiological studies of polypharmacy. Methodological issues, population estimates and influence of practice patterns (Thesis). University of South Denmark: Research Unit of General Practice, 1998.
16. Danmarks Statistik. Population in municipalities 1 January 1995. Copenhagen: Danmarks Statistik, 1995.